About Cauro Diagnostics Private Limited
Data last updated:
Cauro Diagnostics Private Limited was a private limited company based in Gurgaon, Haryana, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 01 October 2018.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U74999HR2018PTC076183. Its GSTIN is 06AAHCC7921Q1Z4 (Haryana).
The company had an authorised share capital of ₹20 Lakh and a paid-up capital of ₹9.68 Lakh. It was led by directors Tarun Bhambra and Dhruv Gupta.
Its last annual general meeting (AGM) was held on 01 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at 2nd Floor Prem Tower Kirti Nagar Sector 15, Gurgaon, Haryana, India – 122001.
As per the financials filed for FY 2021, the company reported a revenue of ₹9.7 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹39.86 Lakh (net margin 4.1%) and EBITDA of ₹60.59 Lakh (EBITDA margin 6.2%).
The company was associated with 1 brand: Rapidx Pathology Labs. As per MCA filings, the company had satisfied charges of ₹1.09 Cr on record. The company has 6 deals on record (5 funding rounds, 1 acquisition), with disclosed funding of ₹9.51 Cr; the latest was in August 2022.
The last known website on record is rapidx.co.in.
Company details
Contact details
Cauro Diagnostics Private Limited's registered office is in Gurgaon, Haryana. Its website is rapidx.co.in. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Apps
- Registered Address2nd Floor Prem Tower Kirti Nagar Sector 15, Gurgaon, Haryana, India – 122001
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Cauro Diagnostics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Cauro Diagnostics operates one associated brand: Rapidx Pathology Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Diagnostic pathology services are provided by a standalone laboratory. | rapidx.co.in |
Business activity
The main business activity of Cauro Diagnostics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Cauro Diagnostics Private Limited, buy the company report.
Financials of Cauro Diagnostics Private Limited
FY 2021 filings availableCauro Diagnostics Private Limited reported revenue of ₹9.7 Cr (up 613% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 613% in the latest year. EBITDA rose 223% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹9.7 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹60.59 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹39.86 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 6.2% | ||
| Net Profit Margin | 4.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Cauro Diagnostics Private Limited, buy the company report.
Board of directors of Cauro Diagnostics Private Limited
Cauro Diagnostics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tarun Bhambra Also directs: Orchard Healthcare Private Limited | Additional Director | 08 Dec 2021 | 4 Years 10 Months | As last reported |
| Dhruv Gupta Also directs: PDG Advisors LLP, Orchard Healthcare Private Limited | Additional Director | 08 Dec 2021 | 4 Years 10 Months | As last reported |
Auditor
Cauro Diagnostics Private Limited is audited by ANUP KUMAR & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANUP KUMAR & CO | FY 2021 | 027603N |
Shareholding
The shareholding of Cauro Diagnostics Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cauro Diagnostics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 May 2021 | 100459929 | Hdfc Bank Limited | ₹47.5 Lakh | Satisfied | |
| 12 Mar 2021 | 100469341 | Hdfc Bank Limited | ₹61 Lakh | Satisfied |
To see the full charge records of Cauro Diagnostics Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Cauro Diagnostics Private Limited has 6 deals on record (5 funding rounds, 1 acquisition), with disclosed funding of ₹9.51 Cr; the latest was in August 2022.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2022 | Acquisition | Undisclosed | Buyer: Orchard Healthcare Private Limited |
| Dec 2021 | Funding round | ₹8.67 Cr | Investors: Orchard Healthcare Private Limited |
| Aug 2019 | Funding round | ₹7 Lakh | Investors: an individual |
| Jun 2019 | Funding round | ₹6 Lakh | Investors: an individual |
| Mar 2019 | Funding round | ₹10 Lakh | Investors: an individual |
To see the full deal history of Cauro Diagnostics Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Cauro Diagnostics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cauro Diagnostics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cauro Diagnostics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCC7921Q1Z4 | Haryana | Active | 11 Dec 2018 |
To see the full GST registrations and return filing status of Cauro Diagnostics Private Limited, buy the company report.
Recent activity
Cauro Diagnostics Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Dhruv Gupta was appointed as Additional Director on 08 Dec 2021.
Frequently asked questions
Cauro Diagnostics has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Cauro Diagnostics was a private limited company based in Gurgaon, Haryana, India. The company worked in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 01 October 2018 and is registered under CIN U74999HR2018PTC076183. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Cauro Diagnostics was incorporated on 01 October 2018. It is registered with the Registrar of Companies, Delhi.
Cauro Diagnostics had 2 directors:
- Tarun Bhambra - Additional Director
- Dhruv Gupta - Additional Director
The CIN (Corporate Identification Number) of Cauro Diagnostics is U74999HR2018PTC076183. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Cauro Diagnostics is at 2nd Floor Prem Tower Kirti Nagar Sector 15, Gurgaon, Haryana, India – 122001.
Cauro Diagnostics can be reached through the website rapidx.co.in. Its registered office is in Gurgaon, Haryana, India.
The latest financial statements of Cauro Diagnostics on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 01 November 2021. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Cauro Diagnostics is 06AAHCC7921Q1Z4, registered in Haryana.
Cauro Diagnostics operated in the healthcare industry, in the diagnostic centers and pathology labs segment.